To better delineate perioperative urethroplasty practice patterns among reconstructive urologists given that management strategies in reconstructive urology have generally been poorly described.
An online survey examining perioperative management of anterior urethroplasty patients was administered to Society of Genitourinary Reconstructive Surgeons (GURS) members between August-October 2019. Questions pertained to tissue transfer, pharmacologic prophylaxis, catheter use, follow-up, and post-operative care.
A total of 248 GURS members were invited to participate, with a response rate of 57.2% (n=142). Most participants performed >20 urethroplasties per year (n=108, 76.1%). Almost all respondents (97.9%, n=139) used intraoperative intravenous antibiotics. A minority of surgeons used intraoperative pharmacologic thromboembolism prophylaxis (n=57, 40.1%). Surgeons prefer buccal mucosa for grafting (n=138, 97.2%) with many leaving the donor site open (n=76, 53.5%). Only 21.8% (n=31) of surgeons prescribe bedrest for patients and 25.4% (n=36) routinely place drains. Postoperatively, oral antimicrobials are routinely administered (n=100, 70.4%), with most continuing until the urinary catheter is removed (70, 72.2%). Patients commonly had a urethral catheter for 2-3 (n=72, 58.5%) or 3-4 weeks (n=37, 30.1%). At catheter removal, surgeons routinely perform urethral imaging with contrast (n=96, 67.6%). Most surgeons prefer some form of objective investigation (n=111, 78.2%) [uroflowmetry (n=91, 82.0%), post-void residual (n=88, 79.3%)]. Cystoscopy is also commonly performed (n=64, 57.7%). These investigations are routinely performed at 2-3 (n=49, 44.2%) or 4-6 months (n=38, 34.2%) postoperatively.
Despite general consensus on urethroplasty management options, heterogeneity remains in the areas of antibiotic use, VTE prophylaxis, donor site management, catheter management and follow-up assessment.

Copyright © 2021. Published by Elsevier Inc.